Post by Michael Okun on X. Functional move disorders

YPbCAmgI_normal.jpg spacer.png
Michael Okun
⁦‪@MichaelOkun‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
The final slide of the 5 day Aspen movement disorders course delivered by Professor ⁦‪@AlbertoEspay‬⁩ delivers everything you need to know about the challenges in functional movement disorders in one slide. ⁦‪@movedisorder‬⁩ Aspen course faculty drops the ‘mic.’ See you in 2025. pic.twitter.com/bzQS9eXsPJ
8/3/24, 11:17 AM

Joseph Thornton

Post by Science Magazine GLP 1full benefits. Neuro etc

wUNPvDdW_normal.jpg spacer.png
Science Magazine
⁦‪@ScienceMagazine‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
A new #SciencePerspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders.

Read more: scim.ag/7N0 pic.twitter.com/GrJExkhDpx

7/25/24, 5:00 AM

Joseph Thornton